Hemolytic uremic syndrome in an adolescent with Fusobacterium necrophorum bacteremia.

D. H. Chand, R. C. Brady, J. J. Bissler

    Research output: Contribution to journalArticlepeer-review

    12 Scopus citations


    Microorganisms may produce substances that disrupt the interaction between platelets and vascular endothelium, which has been associated with atypical hemolytic uremic syndrome (HUS). We present the first reported case of Fusobacterium necrophorum bacteremia that presented initially with atypical HUS. Antimicrobial therapy eradicated the patient's bacteremia, and plasmapheresis restored platelet-endothelial homeostasis. Understanding the pathophysiologic mechanisms involved in atypical HUS would guide the development of more precise therapies.

    Original languageEnglish
    Pages (from-to)E22
    JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
    Issue number3
    StatePublished - Mar 2001


    Dive into the research topics of 'Hemolytic uremic syndrome in an adolescent with Fusobacterium necrophorum bacteremia.'. Together they form a unique fingerprint.

    Cite this